Scarica l'app Stockscreener
48.83
0.63%
-0.31
Dopo l'orario di chiusura:
49.35
0.52
+1.06%
Precedente Chiudi:
$49.14
Aprire:
$48.46
Volume 24 ore:
2.63M
Relative Volume:
0.50
Capitalizzazione di mercato:
$8.73B
Reddito:
$1.27B
Utile/perdita netta:
$-245.03M
Rapporto P/E:
-34.70
EPS:
-1.4071
Flusso di cassa netto:
$-245.36M
1 W Prestazione:
-3.95%
1M Prestazione:
-15.74%
6M Prestazione:
-38.37%
1 anno Prestazione:
-17.24%
Intervallo 1D:
$47.69
$49.37
Intervallo di 1 settimana:
$46.13
$50.58
Portata 52W:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
48.83 | 8.78B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
179.11 | 30.45B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.09B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.90B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Artificial Intelligence Stocks To Watch TodayMarch 24th - MarketBeat
Thomas Edward Schoenherr Net Worth (2026) - GuruFocus
Tempus AI Inc. (TEM) touted as a buy amid focus on healthcare opportunities - MSN
Tempus AI Inc. (TEM) Touted as a Buy Amid Focus on Healthcare Opportunities - Insider Monkey
Promising Artificial Intelligence Stocks To Follow NowMarch 23rd - MarketBeat
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story - The Globe and Mail
Tempus AI’s diagnostic and data divisions Propel Sustainable Growth Over Time - Bitget
Best Artificial Intelligence Stocks Worth WatchingMarch 22nd - MarketBeat
Top Artificial Intelligence Stocks To ResearchMarch 21st - MarketBeat
Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape? - TradingView
Market Moves: What is the next catalyst for Tempus AI Inc2026 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
HC Wainwright raises Tempus AI (TEM) price target to $95 - MSN
H.C. Wainwright Raises Tempus AI (TEM) Price Target to $95 - Insider Monkey
Top Artificial Intelligence Stocks To ConsiderMarch 20th - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
10 Best New AI Stocks to Buy - Insider Monkey
Artificial Intelligence Stocks To ConsiderMarch 19th - MarketBeat
JPMorgan lowers Tempus AI (TEM) PT to $80, maintains neutral rating - MSN
Mizuho initiates coverage of Tempus AI (TEM) with outperform recommendation - MSN
3 MedTech stocks poised to gain in 2026 from the AI boom - MSN
Tempus AI Pediatric Leukemia Registry Deepens Oncology Data And Patient Reach - Yahoo Finance Singapore
Tempus AI, Inc. (TEM) announces strategic deal with Merck to fast-track AI-driven precision medicine - MSN
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Weakness? - Yahoo Finance
Promising Artificial Intelligence Stocks To Keep An Eye OnMarch 17th - MarketBeat
Is Tempus AI (TEM) The Best AI Healthcare Stock in Cathie Wood’s Portfolio? - Insider Monkey
Tempus and Blood Cancer United announce collaboration to develop one of the largest pediatric acute myeloid leukemia Real-World Data registries - marketscreener.com
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries - The AI Journal
Best Artificial Intelligence Stocks To Add to Your WatchlistMarch 16th - MarketBeat
Tempus AI Advances Clinical Applications and Healthcare Software - TradingView
Bamco Inc. NY Increases Stake in Tempus AI, Inc. - National Today
Tempus AI, Inc. $TEM Shares Bought by Bamco Inc. NY - MarketBeat
Why Tempus AI, Inc. (TEM) Went Down On Wednesday - MSN
Cathie Wood buys $2 million of tumbling AI stock - MSN
Best Artificial Intelligence Stocks To Follow NowMarch 15th - MarketBeat
Clear Street Group Inc. Acquires Stake in Tempus AI - National Today
Casdin Capital LLC Purchases Shares of 294,127 Tempus AI, Inc. $TEM - MarketBeat
Clear Street Group Inc. Acquires Shares of 716,406 Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks Worth WatchingMarch 14th - MarketBeat
Tempus AI falls despite Q4 beats, 2026 revenue guidance above consensus - MSN
Tempus AI price target lowered to $80 from $85 at JPMorgan - MSN
Top Artificial Intelligence Stocks To Watch NowMarch 13th - MarketBeat
Tempus AI, Inc. $TEM Shares Acquired by Landscape Capital Management L.L.C. - MarketBeat
Tempus AI, Inc. Class A Trade Ideas — BX:TEM - TradingView
Tempus AI, Inc. $TEM Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Tempus AI’s Ambry Genetics Leads with Validated 99.5% Accurate Hereditary Cancer Risk Assessment Tool - MSN
Assessing Tempus AI (TEM) Valuation As New Oncology Study Highlights Clinical Impact Of Its AI Platform - simplywall.st
Tempus AI Inc (TEM) Shares Down 5.14% on Mar 12 - GuruFocus
Tempus AI Expands Clinical Validation of AI-Powered Cancer Diagnostics - Yahoo Finance
First Trust Advisors LP Has $47.63 Million Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood’s ARK sells LY Corp stock, buys Tempus AI - Investing.com
Tempus AI Earnings Call Highlights Strong Growth Path - The Globe and Mail
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.87%
2.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):